CATX – perspective therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Truist Financial Co. from $21.00 to $10.00. They now have a "buy" rating on the stock.
Perspective Therapeutics, Inc. (NYSE: CATX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Perspective Therapeutics to Participate in Upcoming April Investor Conferences
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Royal Bank of Canada from $16.00 to $15.00. They now have an "outperform" rating on the stock.
Perspective Therapeutics, Inc. (NYSE: CATX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Form POS AM Perspective Therapeutics
Form 4 Perspective Therapeutics For: Mar 28 Filed by: Spoor Johan M.
Form 4 Perspective Therapeutics For: Mar 28 Filed by: Williamson Robert F III
Form 4 Perspective Therapeutics For: Mar 28 Filed by: Graham Juan
Form 4 Perspective Therapeutics For: Mar 31 Filed by: Woods Lori A
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.